BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 5777260)

  • 1. [On the therapy of shock using isoprenaline].
    Affolter H; Debrunner F; Mannhart M; Ritz R
    Dtsch Med Wochenschr; 1969 Apr; 94(15):774-8. PubMed ID: 5777260
    [No Abstract]   [Full Text] [Related]  

  • 2. Isoproterenol and norepinephrine therapy for pulmonary embolism shock.
    Rosenberg JC; Hussain R; Lenaghan R
    J Thorac Cardiovasc Surg; 1971 Jul; 62(1):144-50. PubMed ID: 5091678
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of shock in a canine model of pulmonary embolism.
    Molloy WD; Lee KY; Girling L; Schick U; Prewitt RM
    Am Rev Respir Dis; 1984 Nov; 130(5):870-4. PubMed ID: 6497165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ineffectiveness of isoproterenol in shock due to acute myocardial infarction.
    Gunnar RM; Loeb HS; Pietras RJ; Tobin JR
    JAMA; 1967 Dec; 202(13):1124-8. PubMed ID: 6072706
    [No Abstract]   [Full Text] [Related]  

  • 5. Reevaluation of the treatment of shock secondary to cardiac infarction.
    Corday E; Vyden JK; Lang TW; Boszormenyi E; Carvalho M; Gold H; Goldman A; Rosselot E
    Dis Chest; 1969 Sep; 56(3):200-9. PubMed ID: 5821787
    [No Abstract]   [Full Text] [Related]  

  • 6. The physiologic basis for treatment of shock associated with myocardial infarction.
    Gunnar RM; Pietras RJ; Stavrakos C; Loeb HS; Tobin JR
    Med Clin North Am; 1967 Jan; 51(1):69-81. PubMed ID: 4869243
    [No Abstract]   [Full Text] [Related]  

  • 7. [The treatment of shock with isoproterenol].
    Gigon JP; Wolff G; Enderlin F
    Schweiz Med Wochenschr; 1966 May; 96(18):597-603. PubMed ID: 4296045
    [No Abstract]   [Full Text] [Related]  

  • 8. [Central venous pressure in control of cardiogenic shock].
    Gavrilescu S; Cotoi S; Riviş I
    Med Interna (Bucur); 1968 Nov; 20(11):1361-8. PubMed ID: 5731992
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiovascular dynamics in human shock.
    McLaughlin JS; Shama Z; Hirsch E; Khazei AH; Attar S; Cowley A
    Am Surg; 1969 Mar; 35(3):166-76. PubMed ID: 5774446
    [No Abstract]   [Full Text] [Related]  

  • 10. A hemodynamic comparison of dopamine and isoproterenol in patients in shock.
    Talley RC; Goldberg LI; Johnson CE; McNay JL
    Circulation; 1969 Mar; 39(3):361-78. PubMed ID: 5766804
    [No Abstract]   [Full Text] [Related]  

  • 11. [Myocardial factors that determine the immediate prognosis in myocardial infarct].
    Fernández-Pellón R; Alvarado Molina M; García Burgos A
    Arch Inst Cardiol Mex; 1969; 39(5):623-33. PubMed ID: 5374306
    [No Abstract]   [Full Text] [Related]  

  • 12. Combined use of isoproterenol and propranolol in cardiogenic shock.
    Stubbs D; Pugh D; Bell H
    Clin Pharmacol Ther; 1970; 11(2):244-50. PubMed ID: 5416854
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of isoprenaline in the therapy of shock.
    Du Plessis JM; Du Toit HJ; Bull AB; Rorke MJ
    S Afr Med J; 1967 May; 41(21):524-7. PubMed ID: 6028392
    [No Abstract]   [Full Text] [Related]  

  • 14. Protective effects of nylidrin and isoproterenol against hemorrhagic shock.
    Grega GJ; Kinnard WJ
    J Pharmacol Exp Ther; 1968 May; 161(1):98-110. PubMed ID: 5648505
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hemodynamic study of 14 cases of toxic coma (barbiturates, phenothiazines, tranquilizers)].
    Gajdos P; Diamant-Berger F; Rapin M; Goulon M
    Eur J Toxicol; 1970; 3(1):24-35. PubMed ID: 5520459
    [No Abstract]   [Full Text] [Related]  

  • 16. Hemodynamic effects of isoproterenol in cardiac surgery.
    Beregovich J; Reicher-Reiss H; Kunstadt D; Grishman A
    J Thorac Cardiovasc Surg; 1971 Dec; 62(6):957-64. PubMed ID: 5129399
    [No Abstract]   [Full Text] [Related]  

  • 17. Hemodynamics and blood flow distribution in experimental shock. The effect of noradrenaline and isoproterenol.
    Dedichen H
    J Oslo City Hosp; 1989 Mar; 39(3):23-9. PubMed ID: 2723876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cardiogenic shock following myocardial infarct. Therapeutic results with isoprenaline and low-molecular dextran].
    Nager F; Lichtlen P; Rösli R; Steinbrunn W; Gutschmidt A; Reutter F; Blankart R; Reichmuth J; Burger H; Affolter H; Debrunner F; Ritz R; Uehlinger A; Meyer HA
    Dtsch Med Wochenschr; 1969 Aug; 94(33):1640-5. PubMed ID: 5795243
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of corticosteroids on the circulation in shock: experimental and clinical results.
    Motsay GJ; Alho A; Jaeger T; Dietzman RH; Lillehei RC
    Fed Proc; 1970; 29(6):1861-73. PubMed ID: 5482719
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical shock: a hemodynamic and metabolic assessment of treatment.
    McLaughlin JS; Santos D; Khazei H; Attar S; Mansberger A; Cowley RA
    Am Surg; 1967 Sep; 33(9):687-95. PubMed ID: 6036381
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.